Health Level Seven® International

HL7 Genomics Conference
Washington, DC February 20-21, 2018
[HL7.org]

 

Register Today!

Registration

Home

Sponsors






Program Schedule

Schedule and Invited Speakers at a Glance

Day One: Tuesday, February 20


7:45 – 8:15 AM

Registration

8:15 – 8:30 AM

Welcome and Conference Kick-off

  • Charles Jaffe, MD, PhD, Chief Executive Officer, HL7
  • Ticia Gerber, MHS/HP, Global Director, Partnerships and Policy, HL7
  • Grant Wood, Intermountain Precision Genomics, Intermountain Healthcare; Co-Chair, HL7 Clinical Genomics Workgroup

8:30 – 9:00 AM

Morning Keynote: Genomics and AI: Opportunities on the Horizon

  • Paul Varghese MD, Head, Health Informatics, Verily (Google) Lifescience 

9:00 – 9:30 AM

Morning Keynote: "Intelligent" Conclusions, Seeing Through the Hype to Find Real Innovation

  • Grant Wood, Intermountain Healthcare

9:30 – 10:00 AM

New Space, New Technology, New Possibilities: Entrepreneurial Innovation at the Intersection of Artificial Intelligence (AI) and Healthcare

  • Abhi Gholap, Chairman and Co-Founder, OptraHealth 

10:00 – 10:15 AM

Morning Break

10:15 – 11:00 AM

Collaborative and Network Genomics Initiatives: Healthcare Provider, Patient and Interoperability Impacts (Panel Discussion)

  • Brian Bot, Prinicpal Scientist and Community Manager, Sage Bionetworks 
  • Alexandra C. Ehrlich, Principal Solutions Consultant, Oracle Health Sciences 

11:00 – 12:00 PM

Key Policy Issues in National Genomics and Interoperability in the Artificial Intelligence Age

  • Ticia Gerber, MHS/HP, Global Director, Partnerships and Policy, HL7 Moderator 
  • Leigh Burchell, Vice President, Government Relations, AllScripts 
  • Lauren Riplinger, JD, Senior Director, Federal Relations, AHIMA
  • Mari Savickis, Vice President, Federal Affairs, CHIME 
  • Mark J. Segal, PhD, FHIMSS, Principal, Digital Health Advisors, LLC  
  • Jeffrey Smith, MPP, Vice President, Public Policy, AMIA

12:00 – 1:00 PM

Networking Lunch

1:00 – 1:30 PM

Afternoon Keynote: Use Cases Supported by FHIR Genomics: Innovation, Implementation and Vital Data Sharing

  • Gil Alterovitz, PhD, Assistant Professor, Division of Medical Sciences/Computational Health Informatics, Harvard Medical School/Boston Children's Hospital; Co-Chair, HL7 Clinical Genomics Workgroup

1:30 – 2:00 PM

Private Sector Innovation and Entrepreneurship in Genomics

  • Julianna Kohler, M.H.S,. Data Science Lead ConvergeHEALTH by Deloitte

2:00 - 4:00 PM

Interactive Genomics Work Session

Goals and Discussion Topics

Policy Issues

2:00pm – Brainstorm guiding principles and critical policy issues at the intersection of genomics and AI.

Research and Clinical Genomics Applications

2:30pm – Explore most promising, feasible, ideas for Genomics and AI in research and in clinical applications over the next few years; List the issues to tackle in achieving these goals.

Use of FHIR Genomics Standards

3:00pm – Outline steps to optimize use of FHIR Genomics standards in Genomics and AI applications. Identify critical areas to solve existing or future data interoperability requirements.

Critical Data Sets

3:30pm – Identify specific data sets critical for making the analysis of Genomics and AI possible and successful – including data sets that are currently in silos, not currently collected, and that need to be combined; Explore data and other issues to address that will enable required data sharing.

 

Day Two: Wednesday, February 21


7:45 – 8:30 AM

Registration

8:30 AM

Welcome, Conference Day Kick-off and Opening Address: FHIR and the Future of Healthcare

  • Charles Jaffe, MD, PhD, Chief Executive Officer, HL7

8:30 – 8:45 AM

Morning Briefnote: An Overview of the NHGRI 2020 Vision for Genomics

  • Cristina Kapustij, Chief of Policy and Program Analysis, NHGRI 

8:45 – 9:15 AM

Morning Keynote: All of Us National Research Program: Building the Foundation, Setting Future Milestones

  •  Bradley Ozenberger, PhD, Program Director, Data Resources and Genomics Platform, All of Us Research Program, Precision Medicine Initiative, National Institutes of Health (NIH), U.S. Department of Health and Human Services 

9:15 – 10:00 AM

Morning Keynote: Progressing Forward: Leveraging the Current Policy and Regulatory Environment for Good

  •  Mark J. Segal, PhD, FHIMSS, Principal, Digital Health Advisors, LLC; Chair, Policy Advisory Committee, HL7 

10:00 – 10:30 AM

Morning Keynote: The Future of International Collaboration: Policy and Technology Considerations

  • Peter Goodhand, Director, Global Alliance for Genomics and Health 

10:30 – 11:00 AM

Morning Break

11:00 – 11:45 AM

Preparing for Tomorrow's Future Today: Scan of Genomics, AI, Informatics and Machine Learning

  • Sam Hanna, MBA, CBCP, CISA, CRISC, Program Director, Masters of Science in Management of Healthcare Informatics and Analytics (MHIA), George Washington University School of Public Health

11:45 – 12:30 PM

Luncheon Address: The Rise of AI Assist: Genomics + Data Liquidity.

  • Pete Celano, MBA, Director of Consumer Health, MedStar Institute for Innovation

12:30 – 3:30 PM

Interactive Genomics Work Session

Goals and Discussion Topics

Patient and Healthcare Consumer Applications

12:30 pm – Brainstorm most promising, feasible ideas for Genomics and AI in patient and healthcare consumer applications over the next few years; List the issues to overcome in achieving these goals.

Global Genomics, Public Health and Implementation

1:30 pm – List benefits and issues of Genomics and AI in public health, national genomic initiatives, and global implementation (mostly for LMICs).

Genomics and AI Action Agenda: Key Components and Collaborations

2:00pm – Create a new grassroots coalition that will develop a plan to promote the action agenda, identify key stakeholders and strategic partnerships, and drive new collaborations.

Wrap-up and Next Steps

3:00pm – Review the previous action agenda sessions to finalize the draft document. Identify the important next steps and timeline.